1. Home
  2. VCEL vs BPYPO Comparison

VCEL vs BPYPO Comparison

Compare VCEL & BPYPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vericel Corporation

VCEL

Vericel Corporation

HOLD

Current Price

$35.51

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Logo Brookfield Property Partners L.P.

BPYPO

Brookfield Property Partners L.P.

HOLD

Current Price

$14.75

Market Cap

0.0

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
VCEL
BPYPO
Founded
1989
N/A
Country
United States
Bermuda
Employees
N/A
30200
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Real Estate
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
N/A
IPO Year
1997
N/A

Fundamental Metrics

Financial Performance
Metric
VCEL
BPYPO
Price
$35.51
$14.75
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$57.50
N/A
AVG Volume (30 Days)
578.6K
N/A
Earning Date
11-06-2025
N/A
Dividend Yield
N/A
N/A
EPS Growth
236.54
N/A
EPS
0.25
N/A
Revenue
$258,716,999.00
N/A
Revenue This Year
$17.86
N/A
Revenue Next Year
$18.55
N/A
P/E Ratio
$144.40
N/A
Revenue Growth
14.05
N/A
52 Week Low
$29.24
N/A
52 Week High
$63.00
N/A

Technical Indicators

Market Signals
Indicator
VCEL
BPYPO
Relative Strength Index (RSI) 39.93 55.43
Support Level $35.53 $14.28
Resistance Level $38.15 $14.85
Average True Range (ATR) 1.26 0.23
MACD -0.11 0.02
Stochastic Oscillator 19.64 77.05

Price Performance

Historical Comparison
VCEL
BPYPO

About VCEL Vericel Corporation

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

About BPYPO Brookfield Property Partners L.P.

Brookfield Property Partners LP owns, operates, and invests in commercial properties in North America, Europe, Australia, and Brazil. The company focuses on being an owner and operator of real estate, providing investors with diversified exposure to some of the iconic properties and acquiring high-quality assets at a discount to replacement cost or intrinsic value. Its operating segment includes Core Office, Core Retail, LP Investments, and Corporate Segments. The company operates in various sectors such as the office sector, retail sector, industrial, multifamily, hospitality, triple net lease, and corporate sector. It generates a majority of revenue from the LP Investments segment.

Share on Social Networks: